<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0003146'>Hypocholesterolemia</z:hpo> of unknown etiology has been previously described in various <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001903'>anemias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Few small studies also suggested that those patients have a lower incidence of atherosclerotic events </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of our study was to determine the extent of <z:hpo ids='HP_0003146'>hypocholesterolemia</z:hpo> in various types of <z:hpo ids='HP_0001903'>anemias</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We studied 59 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001903'>anemias</z:hpo> associated with high-erythropoietic activity (<z:e sem="disease" ids="C0271979" disease_type="Disease or Syndrome" abbrv="">thalassemia intermedia</z:e>, <z:hpo ids='HP_0004810'>congenital dyserythropoietic anemia</z:hpo> type I, congenital <z:hpo ids='HP_0004444'>spherocytosis</z:hpo>), 8 patients with low-erythropoietic activity <z:hpo ids='HP_0001903'>anemias</z:hpo> (acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, Fanconi <z:hpo ids='HP_0001903'>anemia</z:hpo>, and Diamond Blackfan <z:hpo ids='HP_0001903'>anemia</z:hpo>), and 20 healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>Mean serum cholesterol, <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol, <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) cholesterol, <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:chebi fb="0" ids="35143">hemoglobin</z:chebi>, serum ferritin, soluble transferrin receptor (STR), and serum erythropoietin levels were determined in each patient </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001903'>anemia</z:hpo> and increased erythropoietic activity had <z:hpo ids='HP_0003146'>hypocholesterolemia</z:hpo>, whereas none of those with low erythropoietic activity was hypocholesterolemic </plain></SENT>
<SENT sid="6" pm="."><plain>Mean serum cholesterol, <z:chebi fb="4" ids="47775">HDL cholesterol</z:chebi>, and <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> levels were found to be significantly lower in the high-erythropoietic activity group (80+/-19 mg/dl; 31+/-10 mg/dl; 35+/-14 mg/dl, respectively) compared with the control group (P&lt;0.001; 0.001; 0.001, respectively) and the low-erythropoietic activity group (P&lt;0.001; 0.001; 0.01, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Significant inverse correlation (R2=0.507) was observed between serum cholesterol and STR levels, which in the absence of <z:e sem="disease" ids="C0240066" disease_type="Disease or Syndrome" abbrv="">iron deficiency</z:e> reflect bone marrow activity </plain></SENT>
<SENT sid="8" pm="."><plain>Taken together, our results imply that <z:hpo ids='HP_0003146'>hypocholesterolemia</z:hpo> accompanies <z:hpo ids='HP_0001903'>anemias</z:hpo> with high-erythropoietic activity </plain></SENT>
<SENT sid="9" pm="."><plain>We suggest that the high-erythropoitic activity-associated <z:hpo ids='HP_0003146'>hypocholesterolemia</z:hpo> is due to increased cholesterol requirements by the proliferating erythoid cells </plain></SENT>
<SENT sid="10" pm="."><plain>Further studies are needed to elucidate the exact mechanism and the possible clinical consequences of this phenomenon </plain></SENT>
</text></document>